Seqirus

Patent cliffs & loss of exclusivity

Seqirus is a Parkville, Victoria-based developer of vaccines for influenza based illness.

Company

AngelList URLhttps://angel.co/company/seqirus
Business ModelCommerce
Crunchbase URLhttps://www.crunchbase.com/organization/seqirus
Facebook URLhttps://www.facebook.com/cslbiotechnology/
Full AddressPoint, Level 3, 29 Market Street Maidenhead SL6 8AA United Kingdom
Instagram URLhttps://www.instagram.com/seqirusinc/
LinkedIn URLhttps://www.linkedin.com/company/seqirusaustralia/
Twitter URLhttps://twitter.com/csl

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. Fluad,Fluad QuadrivalentInfluenza Vaccine, AdjuvantedBiologicFeb 2032
  2. Flucelvax, Flucelvax QuadrivalentInfluenza VaccineBiologicMar 2036

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Seqirus — patent cliffs & loss of exclusivity | CliffBio